NEO-6860

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNEO-6860
Drug Alias NameTRPV1 antagonist - NEOMEDVanilloid receptor 1 ion channel antagonist - NEOMEDNEO-6860
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPainOsteoarthritis, KneeMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeomed Institute
China Registration ClassN/A

Develop Information

Active CompaniesNeomed Institute
Inactive CompaniesN/A
Active IndicationsMusculoskeletal Diseases
Inactive IndicationsPainOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A